E
Profound Medical Corp. PRN.TO
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025
Revenue -20.73% -22.64%
Total Other Revenue -13.33% -31.91%
Total Revenue -15.64% -29.26%
Cost of Revenue -22.79% -34.97%
Gross Profit -12.68% -26.58%
SG&A Expenses 13.58% 24.45%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 16.17% 10.61%
Operating Income -23.64% -27.48%
Income Before Tax -46.32% -91.73%
Income Tax Expenses 56.10% 117.23%
Earnings from Continuing Operations -46.35% -101.05%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -46.35% -101.05%
EBIT -23.64% -27.48%
EBITDA -24.19% -31.22%
EPS Basic -46.27% -72.46%
Normalized Basic EPS -46.24% -64.54%
EPS Diluted -46.27% -72.46%
Normalized Diluted EPS -46.24% -64.54%
Average Basic Shares Outstanding 0.04% 16.57%
Average Diluted Shares Outstanding 0.04% 16.57%
Dividend Per Share -- --
Payout Ratio -- --